Quantcast
Last updated on April 18, 2014 at 6:03 EDT

Latest Neoadjuvant chemotherapy Stories

2012-06-11 21:47:03

A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn't effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. The study by lead author Justin Balko, Pharm.D., Ph.D., was published online June 10, 2012 in Nature Medicine in advance of print publication. Balko is a postdoctoral fellow in the laboratory of Carlos L....

2012-05-23 05:37:19

(Ivanhoe Newswire) — A new study shows that magnetic resonance imaging (MRI), when compared with clinical examination, can actually give an earlier indication of a breast tumor´s response to pre-surgical chemotherapy. Research shows that women who receive chemotherapy before surgery, known as neoadjuvant chemotherapy, are more likely to achieve breast conservation compared with those receiving chemotherapy after surgery. Traditionally, clinicians monitor the patient´s...

2011-09-09 11:26:17

Approach may help some women avoid mastectomy Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, according to a study by researchers at The University of Texas MD Anderson Cancer Center. Presented today at the 2011 Breast Cancer Symposium, the study also found that neoadjuvant chemotherapy (given before surgery),...

2011-08-30 11:11:11

A new study has shown that magnetic resonance imaging (MRI) used to evaluate responses to pre-surgery (neo-adjuvant) chemotherapy or radiation may predict survival among patients with advanced rectal cancer. The findings suggest that MRI-assessed tumor responses to neoadjuvant therapy can help physicians to better plan their patients' subsequent treatments. MRI prior to surgery could help in the management of patients in a number of ways, including offering more intense therapy or...

2011-08-23 19:33:09

Amid the controversy surrounding the Food and Drug Administration's ruling that Avastin should no longer be used to treat metastatic breast cancer, a new multinational Phase III clinical trial shows that Avastin significantly increased tumor response rates in breast cancer patients when given before surgery. At the annual meeting for the American Society of Clinical Oncology, the nation's premier association of clinical oncologists, Harry D. Bear, M.D., Ph.D., Chair, Division of Surgical...

2011-02-28 15:22:34

Researchers from Boston University School of Medicine (BUSM) have found that patients with node negative T3 and T4 non-small lung cancer who underwent chemotherapy before surgery had more than three times the survival rate than patients who only underwent surgery. These findings currently appear on-line in the Journal of Thoracic and Cardiovascular Surgery. The study looked at a total of 110 patients who underwent surgical resection for invasive T3 and T4 non-small lung cancer between 1979...

2010-11-04 07:00:00

WASHINGTON, D.C., Nov. 4, 2010 /PRNewswire/ -- Dr. Christine Teal, Chief of Breast Surgery, and others of The George Washington University Medical Center in Washington, D.C., determined that Breast-Specific Gamma Imaging/Molecular Breast Imaging (BSGI/MBI) is accurate in establishing tumor size within 5 mm after receiving neoadjuvant chemotherapy (pre-chemotherapy) in patients with breast cancer. The data from the retrospective study demonstrated that BSGI was superior to that of other...

2010-05-26 08:05:00

SAN DIEGO, May 26 /PRNewswire/ -- In a recent study presented at the American Association of Cancer Research Annual Meeting in Washington, DC, researchers at the University of Texas MD Anderson Cancer Center showed that Positron Emission Mammography (PEM) helps evaluate response to neoadjuvant chemotherapy. PEM scanners are high-resolution breast PET systems that can show the location as well as the metabolic phase of a lesion. This information is critical in determining whether a lesion...

2010-04-30 07:00:00

NEWPORT NEWS, Va., April 30 /PRNewswire/ -- A new study, presented at the American Society of Breast Surgeons Annual Meeting in Las Vegas, found that Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring the response of breast cancers to neoadjuvant chemotherapy. BSGI, a molecular breast imaging technique (MBI), has been proven in several other studies to improve breast cancer detection and aid in the management of patients with difficult to diagnose breast tissue. The...

2010-04-21 06:46:45

In research published this week in PLoS Medicine, Jörg Kleeff from Technische Universität Mnchen, and colleagues suggest that patients with apparently locally non-resectable tumors should be included in neoadjuvant protocols. The authors systematically reviewed studies concerning the effects of neoadjuvant therapy on tumor response, toxicity, resection, and survival percentages in pancreatic cancer. Pancreatic ductal adenocarcinoma is the fourth leading cause of cancer-related...